Study S001788

Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function in Newly-diagnosed Type 2 Diabetic Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01790308
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 100
Start: 2013-02
Primary completion: 2014-12
Lead sponsor: Sun Yat-sen University
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:CSII; DRUG:Liraglutide
Results posted: FALSE

Registered primary outcomes

the percentage of the patients who maintain glucose control 1 year after short intensive therapy [1 year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.